Transfer of rights to anti-rheumatic agent KOLBET® Tablets in Japan
(WorldNews Japan)

To Whom It May Concern, October 13, 2017 Taisho Pharmaceutical Co., Ltd. Eisai Co., Ltd. Toyama Chemical Co., Ltd. TRANSFER OF RIGHTS TO ANTI-RHEUMATIC AGENT KOLBET® TABLETS 25 MG IN JAPAN Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai"), Toyama Chemical Co., Ltd. of the Fujifilm Group (Headquarters: Tokyo, President: Junji Okada, "Toyama Chemical") and Taisho Pharmaceutical Co., Ltd. (Headquarters: Tokyo, Chief Executive Officer: Shigeru Uehara, "Taisho Pharmaceutical") announced today that Eisai will acquire the marketing authorization and take over the marketing activities for anti-rheumatic agent KOLBET® Tablets 25mg (generic name:...